Bibliography

1. Brzozowski, A. M.; Pike, A. C.; Dauter, Z.; Hubbard, R. E.; Bonn, T.; Engstrom, O.; Ohman, L.; Greene, G. L.; Gustafsson, J. A.; Carlquist, M., Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389, (6652), 753-8.

2. Chamberlain, P. P.; Ren, J.; Nichols, C. E.; Douglas, L.; Lennerstrand, J.; Larder, B. A.; Stuart, D. I.; Stammers, D. K., Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215. J Virol 2002, 76, (19), 10015-9.

3. Chen, Z.; Li, Y.; Chen, E.; Hall, D. L.; Darke, P. L.; Culberson, C.; Shafer, J. A.; Kuo, L. C., Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. J Biol Chem 1994, 269, (42), 26344-8.

4. Coste, F.; Malinge, J. M.; Serre, L.; Shepard, W.; Roth, M.; Leng, M.; Zelwer, C., Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site. Nucleic Acids Res 1999, 27, (8), 1837-46.

5. Fox, K. M.; Maley, F.; Garibian, A.; Changchien, L. M.; Van Roey, P., Crystal structure of thymidylate synthase A from Bacillus subtilis. Protein Sci 1999, 8, (3), 538-44.

6. Gelasco, A.; Lippard, S. J., NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry 1998, 37, (26), 9230-9.

7. Lowe, J.; Li, H.; Downing, K. H.; Nogales, E., Refined structure of alpha beta-tubulin at 3.5 A resolution. J Mol Biol 2001, 313, (5), 1045-57.

8. Natesh, R.; Schwager, S. L.; Evans, H. R.; Sturrock, E. D.; Acharya, K. R., Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 2004, 43, (27), 8718-24.

9. Podust, L. M.; Poulos, T. L.; Waterman, M. R., Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci U S A 2001, 98, (6), 3068-73.

10. Rozwarski, D. A.; Grant, G. A.; Barton, D. H.; Jacobs, W. R., Jr.; Sacchettini, J. C., Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 1998, 279, (5347), 98-102.

11. Sawaya, M. R.; Kraut, J., Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry 1997, 36, (3), 586-603.

12. Taylor, N. R.; Cleasby, A.; Singh, O.; Skarzynski, T.; Wonacott, A. J.; Smith, P. W.; Sollis, S. L.; Howes, P. D.; Cherry, P. C.; Bethell, R.; Colman, P.; Varghese, J., Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. J Med Chem 1998, 41, (6), 798-807.